Atlas Trials

everlinQ endoAVF Post Market Study

Clinical trial NCT02682420 · TERMINATED

Trial details

NCT number
NCT02682420
Sponsor
C. R. Bard
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Chronic Kidney Disease
Start date
2016-09-20
Primary completion
2019-08-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.